	Antipsychotic prescribing patterns and determinants in first-episode psychosis: a 2019-2024 cross-sectional study from Zambia. BMC Psychiatry Moyo LT, Tembo TM, Maila B. PMID: 41618218 [PubMed - as supplied by publisher]
	The role of apolipoproteins as genetic biomarkers in schizophrenia: A systematic review. Med J Malaysia Wan Noorainna Fatimi WMZ, Nour El Huda AR, Norlelawati AT, Mohd Asyraf AJ, Kaderi MA, Norbaiyah MB, Wan Muhamad Salahudin WS, Rinesh Ram M, Norainin Sofiya A, Rasid SNM. PMID: 41617524 [PubMed - indexed for MEDLINE]
	Transcriptomic integration nominates FOXN2 as a candidate schizophrenia risk gene. Behav Brain Res Yu L, Chen J, Du S, Long Q, Guo Z, Liu Y, Qin F, Wang M, Luo R, Zhang Y, Zeng Y, Teng Z. PMID: 41616909 [PubMed - as supplied by publisher]
	More Than Hunger: A Qualitative Study of Food Insecurity and Relational Coping Among Individuals with Schizophrenia-Spectrum Psychotic Disorders and Their Case Managers. Issues Ment Health Nurs Ketel C, Abrams T, Beebe L. PMID: 41616309 [PubMed - as supplied by publisher]
	Personalizing Clozapine in Treatment-Resistant Schizophrenia: The Role of MicroRNA Biomarkers-A Pilot Study. Curr Issues Mol Biol Sosin DN, Khasanova AK, Illarionov RA, Popova AK, Mirzaev KB, Glotov AS, Mosolov SN, Sychev DA. PMID: 41614784 [PubMed]
	PEPAMARKER: a multicenter cohort study protocol on predictive biomarkers of affective vs. non-affective trajectories in first-episode psychosis. Front Psychiatry Terrisse R, Lemey C, Kim-Dufor DH, Miglianico L, Stéphan F. PMID: 41614097 [PubMed]
	From Theory to Therapy: The Evolution and Future of Cognitive-Behavioral Therapy for Psychosis in U.S. Mental Health Care. Focus (Am Psychiatr Publ) Kopelovich SL, Brown P, Hardy K. PMID: 41613750 [PubMed]
	Why Not Rock the Boat? Deprescribing Anticholinergic Medications That Are No Longer Needed in Persons With Schizophrenia. Focus (Am Psychiatr Publ) Gannon JM, Chengappa KNR, Lupu AM, Brar JS. PMID: 41613749 [PubMed]
	Xanomeline-Trospium for the Treatment of Schizophrenia. Focus (Am Psychiatr Publ) Ehret MJ, Meyer JM. PMID: 41613741 [PubMed]
	Smartphone Apps and Digital Tools for Managing Schizophrenia and Psychotic Disorders: A Clinical Review. Focus (Am Psychiatr Publ) Xia W, Hau C, Firth J, Kimhy D, Torous J. PMID: 41613740 [PubMed]
	The Role of Amphiregulin and Epidermal Growth Factor Receptor in First-Episode Psychosis: Exploring Links to Schizophrenia Pathophysiology. Noro Psikiyatr Ars Ta, Ye, Ç, Karamustafal. PMID: 41613037 [PubMed]
	Correction: Transition rates to schizophrenia and early intervention effectiveness in substance-induced and brief psychotic disorders: a randomized controlled trial. Sci Rep Abouzed M, Gabr A, Elsheikh M, Elag KA, Zeid MY, Barakat M, Elasaly E, Elsaadouni N, Soliman M. PMID: 41611941 [PubMed - in process]
	Parsing the neuroanatomy of schizophrenia to enhance the translational validity of preclinical models - a multidisciplinary perspective. Prog Neuropsychopharmacol Biol Psychiatry Morris BJ. PMID: 41611010 [PubMed - as supplied by publisher]
	Small EVs miRNA profiles and their expressions in EVs-depleted plasma as an optimal combination panel for treatment-resistant schizophrenia. Schizophr Res Chen BY, Lin JJ, Tseng HH, Huang CC, Chen PS, Li CH, Yao CY, Cheng WL, Wang TY, Jang FL, Lin SH. PMID: 41610752 [PubMed - as supplied by publisher]
	A comparative study of medication adherence in schizophrenia patients receiving clozapine and other antipsychotics. Psychiatry Res Chanalia S, Grover S, Chakrabarti S. PMID: 41610565 [PubMed - as supplied by publisher]
	New Pharmacological Treatment Approaches for Schizophrenia: Navigating the Post-iclepertin Landscape. CNS Drugs Englisch S, Zink M. PMID: 41609993 [PubMed - as supplied by publisher]
	An observational study on the effects of as-needed use of various antipsychotic drugs for agitation due to psychotic disorders. Int Clin Psychopharmacol Hatta K, Morikawa F, Yamasaki S, Ishizuka T, Nakamura M, Hino K, Katayama S, Imai A, Fujita K, Sugiyama N, JAST study group. PMID: 41609240 [PubMed - as supplied by publisher]
	Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials. Ther Adv Psychopharmacol Anand R, Turolla A, Chinellato G, Sansi F, Roy A, Hartman R. PMID: 41607530 [PubMed]
	Impact of Offender Schizophrenia Diagnosis on Public Perceptions of Crime and Punishment. Behav Sci Law Queen MM, Goncy E. PMID: 41607359 [PubMed - as supplied by publisher]
	Mapping intrinsic brain activity and multilevel mechanisms underlying auditory verbal hallucinations in schizophrenia: A systematic review and meta-analysis. Neurosci Biobehav Rev Xie Y, Zhang T, Ouyang A, Muzhen G, Lin X, Wang L, Diao X, Li Y, He W, Dong Q, Zeng L, Li C, Wang H, Fang P. PMID: 41605340 [PubMed - as supplied by publisher]

Articles 1 - 20 / 67914

Page 1 of 3396



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy